3649 results for «414»
3649 results
Cases on hypertension and heart failure
08 Oct 2021 – From AICT AsiaPCR 2021
Watch this session to discover two cases on hypertension and heart failure: PTRA using DES of chronically occluded renal artery secondary to Takayasu aorto-arteritis in child, and transcatheter closure of acquired ventricular septal rupture.
Small but strong - Semi-compliant balloon in complex and complicated PCI case
09 Oct 2021 – From AICT-AsiaPCR 2021
Watch this session about complex and complicated PCI cases to discover strategies that simplify their management, to understand the intricacies of a semi-compliant balloon design, and to learn techniques to expertly utilize such a balloon.
Cases on complications of coronary perforation: STEMI & NSTEMI
08 Oct 2021 – From AICT AsiaPCR 2021
Watch this session to learn more about complications of coronary perforation, thanks to a selection of two challenging cases: a percutaneous ventricular support device absorbing guidewire during STEMI PCI, as well as a guidewire-induced perforation of tortuous small distal coronary artery.
AsiaPCR/SingLIVE 2017: Opening Ceremony
19 Jan 2017 – From AsiaPCR/SingLIVE 2017
Consult the Opening ceremony of the AsiaPCR/SingLIVE 2017 course edition, the Chien Foundation Award for outstanding lectureship and lifetime achievement in PCI is awarded to Prof. A. Seth.
Chairperson
Innvolution Healthcare reports one-year findings from the ALCHEMY study evaluating Eternia in 1000 patients at EuroPCR 2026
27 May 2026
Four-Year Outcomes from the EVOLUT Low Risk Trial
26 Oct 2023
Dejan Milasinovic provides his take on the EVOLUT Low Risk trial, presented by Michael I. Reardon at TCT Congress 2023. 4-year results reveal a continuing trend towards lower combined rates of all-cause mortality and disabling stroke with TAVI compared with surgical aortic valve replacement (SAVR)
Author
5-year outcomes after transcatheter or surgical aortic valve replacement in low-risk patients with aortic stenosis (Evolut Low Risk)
01 Apr 2025
Yohei Ohno provides his takeaways from the results of the Evolut Low Risk trial which was presented by Michael J. Reardon during the ACC.25 in Chicago.
Author
Transcatheter vs surgical aortic valve replacement in aortic stenosis patients at low surgical risk: 3-year outcomes from the Evolut Low Risk trial
05 Mar 2023
Luigi Biasco provides his take on the clinical trial presented by John K. Forrest from Yale University School of Medicine, New Haven, Connecticut, USA during the 2023 ACC/WCC annual congress held in New Orleans, Louisiana.
Author
Cardiac biomarkers in patients with asymptomatic severe aortic stenosis: primary biomarker analysis from the EARLY TAVR Trial
01 Apr 2025
Elad Asher provides his take on the primary biomarker analysis from the EARLY TAVR Trial presented by Brian R. Lindman at ACC.25 in Chicago.
Author
